Patents by Inventor Eun Ji JU

Eun Ji JU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11053190
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: July 6, 2021
    Assignee: NeuroBiogen Co., Ltd.
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Publication number: 20200308104
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 1, 2020
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK
  • Patent number: 10676425
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: June 9, 2020
    Assignee: MEGABIOWOOD CO., LTD
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Publication number: 20170298011
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 19, 2017
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK